Literature DB >> 16682131

Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers.

Stefano Maria Magrini1, Umberto Ricardi, Riccardo Santoni, Marco Krengli, Marco Lupattelli, Ines Cafaro, Silvia Scoccianti, Claudia Menichelli, Filippo Bertoni, Riccardo Maurizi Enrici, Vincenzo Tombolini, Michela Buglione, Luigi Pirtoli.   

Abstract

PURPOSE: To analyze the patterns of practice and survival in a series of 1722 adult astrocytoma patients treated in 12 Italian radiotherapy centers. METHODS AND MATERIALS: A total of 1722 patients were treated with postoperative radiotherapy (90% World Health Organization [WHO] Grade 3-4, 62% male, 44% aged >60 years, 25% with severe neurologic deficits, 44% after gross total resection, 52% with high-dose radiotherapy, and 16% with chemotherapy). Variations in the clinical-therapeutic features in three subsequent periods (1985 through 2001) were evaluated, along with overall survival for the different subgroups.
RESULTS: The proportion of women, of older patients, of those with worse neurologic performance status (NPS), with WHO Grade 4, and with smaller tumors increased with time, as did the proportion of those treated with radical surgery, hypofractionated radiotherapy, and more sophisticated radiotherapy techniques, after staging procedures progressively became more accurate. The main prognostic factors for overall survival were age, sex, neurologic performance status, WHO grade, extent of surgery, and radiation dose.
CONCLUSIONS: Recently, broader selection criteria for radiotherapy were adopted, together with simpler techniques, smaller total doses, and larger fraction sizes for the worse prognostic categories. Younger, fit patients are treated more aggressively, more often in association with chemotherapy. Survival did not change over time. The accurate evaluation of neurologic status is therefore of utmost importance before the best treatment option for the individual patient is chosen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682131     DOI: 10.1016/j.ijrobp.2006.01.026

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology).

Authors:  Silvia Scoccianti; Stefano Maria Magrini; Umberto Ricardi; Beatrice Detti; Marco Krengli; Salvatore Parisi; Filippo Bertoni; Guido Sotti; Samantha Cipressi; Vincenzo Tombolini; Stefano Dall'oglio; Marco Lioce; Calogero Saieva; Michela Buglione; Cristina Mantovani; Giovanni Rubino; Paolo Muto; Vincenzo Fusco; Laura Fariselli; Costantino de Renzis; Laura Masini; Riccardo Santoni; Luigi Pirtoli; Giampaolo Biti
Journal:  Neuro Oncol       Date:  2012-04-25       Impact factor: 12.300

2.  Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004.

Authors:  Luc Bauchet; Hélène Mathieu-Daudé; Pascale Fabbro-Peray; Valérie Rigau; Michel Fabbro; Olivier Chinot; Loreleï Pallusseau; Charlotte Carnin; Karl Lainé; Aline Schlama; Agnes Thiebaut; Maria Cristina Patru; Fabienne Bauchet; Martine Lionnet; Michel Wager; Thierry Faillot; Luc Taillandier; Dominique Figarella-Branger; Laurent Capelle; Hugues Loiseau; Didier Frappaz; Chantal Campello; Christine Kerr; Hugues Duffau; Monique Reme-Saumon; Brigitte Trétarre; Jean-Pierre Daures; Dominique Henin; François Labrousse; Philippe Menei; Jérome Honnorat
Journal:  Neuro Oncol       Date:  2010-04-02       Impact factor: 12.300

3.  Treatment disparities following the diagnosis of an astrocytoma.

Authors:  Paula R Sherwood; Bassam A Dahman; Heidi S Donovan; Arlan Mintz; Charles W Given; Cathy J Bradley
Journal:  J Neurooncol       Date:  2010-05-22       Impact factor: 4.130

4.  Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group.

Authors:  Michela Buglione; Paolo Borghetti; Sara Pedretti; Luca Triggiani; Marco Maria Fontanella; Giannantonio Spena; Salvatore Grisanti; Roberto Liserre; Luigi Pietro Poliani; Stefano Gipponi; Luigi Spiazzi; Stefano Maria Magrini
Journal:  Radiol Med       Date:  2015-03-15       Impact factor: 3.469

5.  Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009-2014.

Authors:  Steinbjørn Hansen; Birthe Krogh Rasmussen; René Johannes Laursen; Michael Kosteljanetz; Henrik Schultz; Bente Mertz Nørgård; Rikke Guldberg; Kim Oren Gradel
Journal:  J Neurooncol       Date:  2018-05-12       Impact factor: 4.130

6.  Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.

Authors:  Sara Pedretti; Laura Masini; Enrico Turco; Luca Triggiani; Marco Krengli; Bruno Meduri; Luigi Pirtoli; Paolo Borghetti; Ludovica Pegurri; Nada Riva; Roberto Gatta; Vincenzo Fusco; Silvia Scoccianti; Alessio Bruni; Umberto Ricardi; Riccardo Santoni; Stefano M Magrini; Michela Buglione
Journal:  J Neurooncol       Date:  2019-05-04       Impact factor: 4.130

7.  Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis.

Authors:  Michela Buglione; Sara Pedretti; Stefano Gipponi; Alice Todeschini; Ludovica Pegurri; Loredana Costa; Laura Donadoni; Salvatore Grisanti; Marco Fontanella; Roberto Liserre; Fabio Facchetti; Alessandro Padovani; Stefano Maria Magrini
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

8.  Multicentre prospective collection of newly diagnosed glioblastoma patients: update on the Lombardia experience.

Authors:  Andrea Salmaggi; Antonio Silvani; Rossella Merli; Manuela Caroli; Giustino Tomei; Annamaria Russo; Maurizio Riva; Enrico Marchioni; Francesca Imbesi
Journal:  Neurol Sci       Date:  2008-05-16       Impact factor: 3.307

9.  A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13-12.

Authors:  Hyun-Cheol Kang; Tosol Yu; Do Hoon Lim; Il Han Kim; Woong-Ki Chung; Chang-Ok Suh; Byung Ock Choi; Kwan Ho Cho; Jae Ho Cho; Jin Hee Kim; Do-Hyun Nam; Chul-Kee Park; Yong-Kil Hong; In Ah Kim
Journal:  J Neurooncol       Date:  2015-09-04       Impact factor: 4.130

10.  Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study.

Authors:  T Hirai; R Murakami; H Nakamura; M Kitajima; H Fukuoka; A Sasao; M Akter; Y Hayashida; R Toya; N Oya; K Awai; K Iyama; J-i Kuratsu; Y Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-12       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.